Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 40

    SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination

    SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination

    Ruby Khatun Khatun16 Dec 2017 3:40 PM IST
    New Delhi: The Supreme Court referred 344 fixed dose combination (FDC) medicines, including well- known brands like Corex cough syrup, Vicks Action...
    Nicotine gums should not be sold OTC-health dept tells DGCI

    Nicotine gums should not be sold OTC-health dept tells DGCI

    Ruby Khatun Khatun13 Dec 2017 4:25 PM IST
    New Delhi: The Delhi government's health department has written to the Drug Controller General of India (DGCI) for stopping the over-the-counter sale...
    India and Cuba sign MoU for pharma regulation, medical devices

    India and Cuba sign MoU for pharma regulation, medical devices

    Ruby Khatun Khatun7 Dec 2017 11:00 AM IST
    New Delhi: India and Cuba inked a MoU for enhanced cooperation in the health sector by pooling in technical, scientific, financial and human...
    New expert panel to help to decide pricing and launch of drugs: DoP

    New expert panel to help to decide pricing and launch of drugs: DoP

    Ruby Khatun Khatun5 Dec 2017 1:43 PM IST
    New Delhi: The government will set up a panel of experts for consultation on matters pertaining to the implementation of the drug price control order,...
    Launch new drugs without prior price approval: NPPA issues guidelines

    Launch new drugs without prior price approval: NPPA issues guidelines

    Ruby Khatun Khatun2 Dec 2017 12:25 PM IST
    Through a recent notification the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
    Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details

    Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details

    Ruby Khatun Khatun24 Nov 2017 4:15 PM IST
    New Delhi: National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the...
    Misuse of Topical Steroid Skin Creams: Delhi HC notice to CDSCO

    Misuse of Topical Steroid Skin Creams: Delhi HC notice to CDSCO

    Ruby Khatun Khatun23 Nov 2017 12:37 PM IST
    New Delhi: The Delhi High Court on Wednesday sought the Centre's response on a plea seeking direction to ensure that no topical medications which...
    Sanofi Pasteurs Expired polio vaccines being used in Gujarat: Probe demanded

    Sanofi Pasteurs Expired polio vaccines being used in Gujarat: Probe demanded

    Ruby Khatun Khatun20 Nov 2017 5:35 PM IST
    25,000 doses of IPV are on the last VVM stage, stated a letter to the health departmentAhmedabad: Injectable Polio Vaccine supplied to the hospitals...
    NPPA invites representation and suggestion on Coronary Stents

    NPPA invites representation and suggestion on Coronary Stents

    Ruby Khatun Khatun14 Nov 2017 4:29 PM IST
    Through a recent notification Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National Pharmaceutical...
    CDSCO grants approval to AstraZeneca India for Breakthrough Therapy of lung cancer

    CDSCO grants approval to AstraZeneca India for Breakthrough Therapy of lung cancer

    Ruby Khatun Khatun13 Nov 2017 5:39 PM IST
    Through a recent notification, Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and...
    Sterling Biotech Case : Dont let shark run away for catching small fish, Court tells ED

    Sterling Biotech Case : Don't let shark run away for catching small fish, Court tells ED

    Ruby Khatun Khatun12 Nov 2017 12:30 PM IST
    New Delhi: "Don't let the shark run away while you are busy in catching the small fish," a Delhi court told the Enforcement Directorate.While allowing...
    MORE DRUGS added to the Schedule H list

    MORE DRUGS added to the Schedule H list

    Ruby Khatun Khatun9 Nov 2017 11:38 AM IST
    Through a recent gazette notification, Ministry of Health And Family Welfare has extended the list of schedule H drugs by adding more drugs to...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok